Form 4: Cassava Sciences CEO Buys Shares
Insider Transaction (Form 4)
Richard Barry, President & CEO and a Director of Cassava Sciences Inc, purchased 306,813 shares of common stock on September 29, 2026.
Summary
- Open-market purchase: acquired 206,813 Common Stock at $0.90 ($186,132) on September 29, 2026; holds 1,237,964 after (Indirect).
- Open-market purchase: acquired 100,000 Common Stock at $0.92 ($92,000) on September 30, 2026; holds 1,337,964 after (Indirect).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $278,132, committing personal capital to the stock.
Insider Transactions
Richard Barry — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-29 | Open-market purchase | Common Stock | 206,813 | $1 | $186.1K | 1,237,964 |
| 2026-09-30 | Open-market purchase | Common Stock | 100,000 | $1 | $92.0K | 1,337,964 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-29 | Open-market purchase (206,813 shares) |
| 2026-09-30 | Open-market purchase (100,000 shares) |
Keywords
insider transaction, Form 4, FLNA, FILANA THERAPEUTICS, INC., bullish, Richard Barry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.